Tag Archives: PATIENTS

Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data

Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More »

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Corona Havoc: COVID-19 patients has crossed 12.6M in Six Months

Coronavirus has wreaked havoc after affecting more than five million people over the world. More than 12.4 M million coronavirus cases have been reported worldwide. According to WorldMeter data, the number of corona positive has reached 12,675,441, and 563,928 people have died due to the epidemic. Corona havoc is not only causing death, but it… Read More »

Abilify information for patients

ABILIFY is used to treat adults and adolescents aged 13 years and older who suffer from a condition with symptoms such as feeling “high”, pathological Gambling and Other Compulsive Behaviors: Compulsive or uncontrollable urges to gamble have been reported with use of aripiprazole. Abilify has been shown to increase the risk of death when used… Read More »